Magazine Article | June 1, 2021

Don't Overlook The Risks Of Innovative Clinical Trials

Source: Life Science Leader

By Nathalie Smyth, Daniel Brettler, Michele Fields, & Camille Hepsworth

The clinical trials landscape is evolving at an unprecedented pace, being both propelled and incentivized by the global race to advance the COVID-19 vaccines. Advancements in AI and machine learning (ML) for data collection and interpretation and a move toward virtual and adaptive trials and use of real-world data (RWD) have paved the way for the development of novel data collection techniques and analysis. These advancements also could increase the threat of cyberattacks and malicious hacking of private medical data.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: